ᐔᚑ ᐕᐲ▤ℂකᏧ% ⢒ᚑᡰេ 㧔 ↢▤ℂක ᛛⴚ᥉ផ 㧕 ߩ⽋㘺㙃ⴡ↢▤ℂᚻᒁᦠ 㧙⮎⠴ᕈ⩶ ߩᛥ ߣലᨐ⊛ ߥᴦ≮㧙 ᐔᚑ ᐕ ኅ⇓ⴡ↢ኻ╷ផㅴද⼏ળ
1
1 12 63 MPC 11 4 20
24 1 24 2 38 3 46
51
1 51 2 61 3 69 4 80
87
③12-02-235.indd iii12-02-235.indd iii 2012/02/21 13:08:352012/02/21 13:08:35
2
1
1.
2
2
PCG ABPC AMPCCEZ CEXFOMSM KM GM AMKCP TPTC MINO DOXYEM CAMLCMERFX OFLX OBFXSDMXTMPCL PL
-2-
12-02-235.indd 212-02-235.indd 2 2012/02/20 20:13:122012/02/20 20:13:12
7
PBP MRSA PBP2'
- ESBL
(efflux)(ribosomal protection)
14 15 16
DNA1
21
-7-
12-02-235.indd 712-02-235.indd 7 2012/02/20 20:13:142012/02/20 20:13:14
8
MIC
Precautionary principle:
1999 4 () 2006
2005 9
( 1)
16 9 30
( 2)“ ”
-8-
12-02-235.indd 812-02-235.indd 8 2012/02/20 20:13:142012/02/20 20:13:14
9
3 300
cross resistance
co-resistanceco-selection
C. jejuni C. coliC. ejuni C. coli
3 Enterococcus faecalis E. faecieumE. hirae MIC
E. faecalis E. faecieumE. hirae
TyphimuriumInfantis
Enteritidis Typhimurium Infantis
-9-
12-02-235.indd 912-02-235.indd 9 2012/02/20 20:13:142012/02/20 20:13:14
11
MPC
WHO / FAO / OIE
[ 2 ]
OIE
EU
-11-
12-02-235.indd 1112-02-235.indd 11 2012/02/20 20:13:152012/02/20 20:13:15
14
OIE
OIE
PK/PD
PK/PD
PK/PD pharmacokinetics PKpharmacodynamics PD PK
PDPK/PD
-14-
12-02-235.indd 1412-02-235.indd 14 2012/02/20 20:13:152012/02/20 20:13:15
15
PK/PD T>MIC Time above MIC 24MIC
Cmax/MICCmax MIC
AUC/MIC AUC area under the curve MIC
T>MIC
AUC/MIC AUCCmax Cmax/MICAUC/MIC
MIC MPC Mutant prevention concentration
MIC10-6 10-8
(mutant) mutant mutantMIC
mutant MPCmutant 1010CFU/spot MIC
MPC MIC mutant (mutant selection window MSW) ( ) MPC MSW PK/PD
Cmax/MPC AUC/MPC Time above MPCMPC
MPC ( ) MPCCmax MSW
MPC Cmax MPC
MSW
-15-
12-02-235.indd 1512-02-235.indd 15 2012/02/20 20:13:152012/02/20 20:13:15
16
WHO/FAO/OIE
10
OIE
MPC
56 685~691 2003
48 437~444(2007) Vose D Acar J Anthony F et al Antimicrobial resistance:risk analysis methodology
for the potential impact on public health of antimicrobial resistant bacteria of animal origin Rev sci tech Off int Epiz 20 811-827 (2001)
25 23~32(2003) Anthony F Acar J Franklin A Gupta R et al Antimicrobial resistance responsible
and prudent use of antimicrobial agents in veterinary medicine Rev sci tech Offint Epiz 20 829-839 (2001)
PK/PD (2006)
-16-
12-02-235.indd 1612-02-235.indd 16 2012/02/20 20:13:152012/02/20 20:13:15
17
Drlica K The mutant selection window and antimicrobial resistance J AntimicrobChemother 52 11-17(2003)
Tran JH Jacoby GA Mechanism o plasmid-mediated quinolone resistance PNAS 99 5638-5642 (2002)
15-22(2003)
10 Harada K Asai T Kojima A et al Contribution of multi-antimicrobial resistance to the population of antimicrobial resistant Escherichia coli isolated from apparently healthy pigs in Japan Microbiol Immunol 51
493-499(2007)
-17-
12-02-235.indd 1712-02-235.indd 17 2012/02/20 20:13:152012/02/20 20:13:15
Cmax
MIC
AUC (Area under the curve)
24 MIC
AUC MIC
Cmax MIC
PK/PD
MIC
AUC (Area under the curve)
MPC
MPC MSW
-18-
12-02-235.indd 1812-02-235.indd 18 2012/02/20 20:13:152012/02/20 20:13:15
21
AGP 10kg
25,00010,000
AGP
AGP
-20-
12-02-235.indd 2012-02-235.indd 20 2012/02/20 20:13:162012/02/20 20:13:16
22
BRD
BRD
39
87.52.4±0.8 41.9 6.3±4.5
-21-
12-02-235.indd 2112-02-235.indd 21 2012/02/20 20:13:162012/02/20 20:13:16
24
Aarestrup FM et al., Changes in the use of antimicrobials and the effects on productivity of
swine farms in Denmark. Am J Vet Res, 71(7), 726-733, 2010 Schaefer AL et al., The use of infrared thermography as an early indicator of bovine
respiratory disease complex in calves. Res Vet Sci, 83(3), 376-384, 2007 , 54 553 557, 2007.
Martinez M, et al., The 2010 AAVPT EAVPT ECVPT bioequivalence workshop. J Vet Pharmacol Therap, 34, 105–107, 2011.
H Allen et al., Antibiotic in swine fed promote gene exchange. Animal Pharm, Dec.9, p.8, 2011
A B
A)B)
-23-
12-02-235.indd 2312-02-235.indd 23 2012/02/20 20:13:162012/02/20 20:13:16
25
3
ETECETEC
ETEC
DHL 16 24ETEC
DHL
-24-
12-02-235.indd 2412-02-235.indd 24 2012/02/20 20:13:162012/02/20 20:13:16
26
2
3ETEC
5
7 14
ETEC
Clostridium perfringens
C.perfringensC. perfringens
3 5
ETEC
-25-
12-02-235.indd 2512-02-235.indd 25 2012/02/20 20:13:162012/02/20 20:13:16
27
PCR
6 17CEZ( ) CTF CL( ) GM() BCM( ) ABPC
AMPC OTC DOXYST
OBFX ERFX( ) NFLX
MARCL
CTF
3
C.perfringens
C. perfringens
C. perfringens
-26-
12-02-235.indd 2612-02-235.indd 26 2012/02/21 10:55:072012/02/21 10:55:07
28
C. perfringens
C. perfringens
2 3
Salmonella Typhimurium S. Derby
S. Typhimurium
S. Typhimurium
S. Typhimurium
S. TyphimuriumS. Typhimurium
-27-
12-02-235.indd 2712-02-235.indd 27 2012/02/21 10:55:072012/02/21 10:55:07
29
Lawsonia intracellularis
L. intracellularisL. intracellularis PCR
L. intracellularisPCR
L. intracellularis
L. intracellularis
L. intracellularis
Brachyspira hyodysenteriae
-28-
12-02-235.indd 2812-02-235.indd 28 2012/02/21 10:55:072012/02/21 10:55:07
C. Perfringens
S. Typhimurium
-34-
12-02-235.indd 3412-02-235.indd 34 2012/02/20 20:13:192012/02/20 20:13:19
40
Mycoplasma hyopneumoniae
+1 +3
1 2 1
2 3
-38-
12-02-235.indd 3812-02-235.indd 38 2012/02/20 20:13:202012/02/20 20:13:20
41
Actinobacillus pleuropneumoniaeActinobacillus pleuropneumoniae 1,2,5
22
ST
Pasteurella multocida
-39-
12-02-235.indd 3912-02-235.indd 39 2012/02/20 20:13:202012/02/20 20:13:20
42
P.multocida
1ST
Bordetella bronchiseptica Pasteurella multocida
B. bronchiseptica P. multocida
-40-
12-02-235.indd 4012-02-235.indd 40 2012/02/20 20:13:202012/02/20 20:13:20
43
PRRS
PRRSPMWS
PRRS
-41-
12-02-235.indd 4112-02-235.indd 41 2012/02/20 20:13:212012/02/20 20:13:21
45
1~21
2~3
PRDC
1 2
3
複雑化する呼吸器病
豚インフルエンザ萎縮性鼻炎
パスツレラ肺炎 胸膜肺炎
マイコプラズマ肺炎豚繁殖・呼吸器障害症候群
PRRS
-43-
12-02-235.indd 4312-02-235.indd 43 2012/02/20 20:13:212012/02/20 20:13:21
48
10
100
1 1
OFLX NFLX1
-46-
12-02-235.indd 4612-02-235.indd 46 2012/02/20 20:13:232012/02/20 20:13:23
49
0.5
0.5
ABPC
AMPC
ABPC
AMPC
CTRX
CTX
CTRX
CTX
KM
GM
KM
GM
NFLX
OFLX
NFLX
OFLX
CP
CL
EM
LCM
TC TC
ST ST ST ST
-47-
12-02-235.indd 4712-02-235.indd 47 2012/02/20 20:13:232012/02/20 20:13:23
50
1 2 0.5
60° 3 1
5
24mm
24mm 24mm
1 7 2
-48-
12-02-235.indd 4812-02-235.indd 48 2012/02/20 20:13:232012/02/20 20:13:23
51
37 24 3 S I R
6 8
100 1,000
100 1,000
-49-
12-02-235.indd 4912-02-235.indd 49 2012/02/20 20:13:232012/02/20 20:13:23
55
+ + +
-3
4 63 5
2-4 5
3 25 11
-4
-5
-53-
12-02-235.indd 5312-02-235.indd 53 2012/02/20 20:13:242012/02/20 20:13:24
56
Kg
-6
-7
-7 9
-10-11
-54-
12-02-235.indd 5412-02-235.indd 54 2012/02/20 20:13:242012/02/20 20:13:24
57
-12 13
-5 6
2 PCV2
-57-
12-02-235.indd 5712-02-235.indd 57 2012/02/20 20:13:242012/02/20 20:13:24
1,600 2,000 2,400 2,800 3,200 3,600 10k 2,100
1,520 1,900 2,280 2,660 3,040 3,420 15k 1,918
1,440 1,800 2,160 2,520 2,880 3,240 20k 1,740
1,360 1,700 2,040 2,380 2,720 3,060 25k 1,696
1,280 1,600 1,920 2,240 2,560 2,880 30k 1,652
1,200 1,500 1,800 2,100 2,400 2,700 35k 1,609
1,120 1,400 1,680 1,960 2,240 2,520 40k 1,566
1,040 1,300 1,560 1,820 2,080 2,340 45k 1,524
960 1,200 1,440 1,680 1,920 2,160 50k 1,482
880 1,100 1,320 1,540 1,760 1,980 55k 1,441
800 1,000 1,200 1,400 1,600 1,800 60k 1,400
720 900 1,080 1,260 1,440 1,620 65k 1,360
640 800 960 1,120 1,280 1,440 70k 1,320
560 700 840 980 1,120 1,260 75k 1,281
480 600 720 840 960 1,080 80k 1,242
400 500 600 700 800 900 85k 1,204
320 400 480 560 640 720 90k 1,166
240 300 360 420 480 540 95k 1,129
160 200 240 280 320 360 100 1,092
80 100 120 140 160 180 200 1,000
10k 2,100
15k 1,918
20k 1,740
25k 1,696
30k 1,652
35k 1,609
40k 1,566
45k 1,524
50k 1,482
55k 1,441
60k 1,400
65k 1,360
70k 1,320
75k 1,281
80k 1,242
85k 1,204
90k 1,166
95k 1,129
100 1,092
200 1,000
-58-
12-02-235.indd 5812-02-235.indd 58 2012/02/20 20:13:242012/02/20 20:13:24
64
2010
1
29 2010 8 27
2010
-61-
12-02-235.indd 6112-02-235.indd 61 2012/02/20 20:13:252012/02/20 20:13:25
72
2010 JASV
21.3 6 21 2008 3( PCV2 )
1,000500 100
PCV2
PRRSPCV2
-69-
12-02-235.indd 6912-02-235.indd 69 2012/02/20 20:13:262012/02/20 20:13:26
73
( )
( ) 12
2 ( )2
LK
2 4
-70-
12-02-235.indd 7012-02-235.indd 70 2012/02/20 20:13:262012/02/20 20:13:26
76
22
2
1 3 7
21
( 2)
3
1 2
1240 70
2 2PCV2
-73-
12-02-235.indd 7312-02-235.indd 73 2012/02/20 20:13:272012/02/20 20:13:27
11.
0.8
1.0
0.6
02
0.4
1.00
5
0.42
4
0.05
1
0.0
0.2
01
23
45
7
-77-
12-02-235.indd 7712-02-235.indd 77 2012/02/20 20:13:272012/02/20 20:13:27
83
Monitoring
-
-
PRRS PCR
-80-
12-02-235.indd 8012-02-235.indd 80 2012/02/20 20:13:282012/02/20 20:13:28
87
0
100
200
300
400
500
600
139 140 141 142 143 144 145 146 147 148 149 150 151 152 153 154 155 156 157 158 159 160
PRRS-P
PCV2
APP-E
PRRS-E
MPS-E
© Ooi
0
2
4
6
8
10
12
14
16
0 100 200 300 400 500 600
%
INDEX
6145
2008-2010
-84-
12-02-235.indd 8412-02-235.indd 84 2012/02/20 20:13:282012/02/20 20:13:28